Literature DB >> 14531730

WBP-2, a WW domain binding protein, interacts with the thyroid-specific transcription factor Pax8.

Roberto Nitsch1, Tina Di Palma, Anna Mascia, Mariastella Zannini.   

Abstract

The Pax gene family encodes transcription factors that are essential in organogenesis and in the differentiation of various organs in higher eukaryotes. Pax proteins have a DNA binding domain at the N-terminus, and a transcriptional activation domain at the C-terminus. How these domains interact with the transcriptional machinery of the cell is still unclear. In the present paper, we describe the identification by means of immunological screening of the WW domain binding protein WBP-2 as a biochemical interactor of Pax8 (a WW domain is a protein-interaction domain containing two conserved tryptophan residues). Pax8 is required for the morphogenesis of the thyroid gland and for the maintenance of the thyroid differentiated cellular phenotype. WBP-2 was identified originally as a WW domain binding protein, and its function is still unknown. WBP-2 binds to Pax8 in vitro in pulldown assays, and in vivo in tissue culture cells in co-immunoprecipitation assays. Interestingly, Pax8 does not contain a WW domain. Our results point to the identification of a new protein-interacting domain that is present in the C-terminal portion of Pax8 and that is required for protein-protein interaction with WBP-2. Our results demonstrate that WBP-2 is not a transcriptional co-activator of Pax8, but rather behaves as an adaptor molecule, as suggested in other studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14531730      PMCID: PMC1223889          DOI: 10.1042/BJ20031233

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  54 in total

Review 1.  ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job.

Authors:  C Muchardt; M Yaniv
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

Review 2.  Functions of WW domains in the nucleus.

Authors:  M Sudol; K Sliwa; T Russo
Journal:  FEBS Lett       Date:  2001-02-16       Impact factor: 4.124

Review 3.  NeW wrinkles for an old domain.

Authors:  M Sudol; T Hunter
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

4.  Protein-protein interaction of retinoic acid receptor alpha and thyroid transcription factor-1 in respiratory epithelial cells.

Authors:  C Yan; A Naltner; J Conkright; M Ghaffari
Journal:  J Biol Chem       Date:  2001-03-23       Impact factor: 5.157

5.  BR22, a novel protein, interacts with thyroid transcription factor-1 and activates the human surfactant protein B promoter.

Authors:  Y S Yang; M C Yang; B Wang; J C Weissler
Journal:  Am J Respir Cell Mol Biol       Date:  2001-01       Impact factor: 6.914

6.  Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8.

Authors:  C Vilain; C Rydlewski; L Duprez; C Heinrichs; M Abramowicz; P Malvaux; B Renneboog; J Parma; S Costagliola; G Vassart
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

7.  Thyroid transcription factor 1 and Pax8 synergistically activate the promoter of the human thyroglobulin gene.

Authors:  C R Espinoza; T L Schmitt; U Loos
Journal:  J Mol Endocrinol       Date:  2001-08       Impact factor: 5.098

8.  Regulation of mouse SP-B gene promoter by AP-1 family members.

Authors:  Z Sever-Chroneos; C J Bachurski; C Yan; J A Whitsett
Journal:  Am J Physiol       Date:  1999-07

9.  Pax8 has a key role in thyroid cell differentiation.

Authors:  M Pasca di Magliano; R Di Lauro; M Zannini
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 10.  A unique combination of transcription factors controls differentiation of thyroid cells.

Authors:  G Damante; G Tell; R Di Lauro
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001
View more
  9 in total

1.  Regulation and function of the TAZ transcription co-activator.

Authors:  Chenying Liu; Wei Huang; Qunying Lei
Journal:  Int J Biochem Mol Biol       Date:  2011-07-20

2.  Mutations in TAZ/WWTR1, a co-activator of NKX2.1 and PAX8 are not a frequent cause of thyroid dysgenesis.

Authors:  A M Ferrara; L De Sanctis; G Rossi; S Capuano; G Del Prete; E Zampella; P Gianino; A Corrias; G Fenzi; M Zannini; P E Macchia
Journal:  J Endocrinol Invest       Date:  2009-03       Impact factor: 4.256

3.  The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway.

Authors:  Zilin Li; Shen Kiat Lim; Xu Liang; Yoon Pin Lim
Journal:  J Biol Chem       Date:  2018-11-15       Impact factor: 5.157

Review 4.  Marking the tempo for myogenesis: Pax7 and the regulation of muscle stem cell fate decisions.

Authors:  Hugo C Olguín; Addolorata Pisconti
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

5.  WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma.

Authors:  Shuai Chen; Ya Zhang; Han Wang; Yu-Ying Zeng; Zhi Li; Ming-Li Li; Fang-Fang Li; Jun You; Zhi-Ming Zhang; Chi-Meng Tzeng
Journal:  Cell Death Dis       Date:  2018-03-01       Impact factor: 8.469

6.  WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1.

Authors:  Zhe Zheng; Yue Li; Siyuan Fan; Jie An; Xi Luo; Minglu Liang; Feng Zhu; Kai Huang
Journal:  Cell Death Dis       Date:  2021-03-03       Impact factor: 8.469

7.  WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression.

Authors:  Qiang Han; Xuezhu Rong; Xuyong Lin; Xiupeng Zhang; Chuifeng Fan; Huanyu Zhao; Enhua Wang
Journal:  Cell Death Dis       Date:  2021-04-09       Impact factor: 8.469

Review 8.  WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer.

Authors:  Shuai Chen; Han Wang; Yu-Fan Huang; Ming-Li Li; Jiang-Hong Cheng; Peng Hu; Chuan-Hui Lu; Ya Zhang; Na Liu; Chi-Meng Tzeng; Zhi-Ming Zhang
Journal:  Mol Cancer       Date:  2017-07-19       Impact factor: 27.401

9.  Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription.

Authors:  Shuai Chen; Han Wang; Zhi Li; Jun You; Qiu-Wan Wu; Can Zhao; Chi-Meng Tzeng; Zhi-Ming Zhang
Journal:  Br J Cancer       Date:  2018-05-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.